Amid increasing demands and evolving health technologies, QURE Healthcare provides innovative solutions to ensure doctors and healthcare practitioners feel confident in their decision-making.
QURE’s scientifically-validated virtual patient platform and practitioner engagement tool is a catalyst of change, creating proven value by not only enhancing real-world practice but by also assessing the “clinical utility” of groundbreaking diagnostic tests and medical technologies.
Trever is a nationally recognized leader in healthcare strategy and has worked extensively with senior health system leaders across the country on projects ranging from demand forecasting and value-based payment structures to clinical technology assessment and cancer center development. In addition, Trever speaks frequently at national conferences on issues on of quality and value in healthcare.
Before joining QURE, Trever served as Vice President at Sg2 (now a division of MedAssets), a healthcare analytics and intelligence company. At Sg2, Trever led the firm’s Center for Clinical Technology as well as the Oncology Strategy team. Trever holds a PhD from Stanford University in Microbiology and Immunology and received his BS from Brigham Young University.
Michael is recognized as a national expert in influencing physician practice patterns at scale. He has developed methods for reducing unwarranted clinical variation through the use of unblinded peer comparisons, facilitated group discussion, mobile phone messages, national claims profiles, and most recently, simulated patients. He has served as senior physician executive at Agathos, Inc, and Embold Health.
He currently leads the development of strategic relationships at QURE Healthcare. Prior roles include Chief Medical Officer at Bay Area Hospital and VP of Variation Reduction at Sutter Health, where his method of pinpointing care variation and facilitating helpful, actionable feedback won physicians’ trust and generated millions in savings.
Czarlota is a practicing internist and subspecializes in nephrology. She oversees quality control of the QURE CPV product and assists in all clinical sciences-related activities.
She holds a degree in Molecular Biology and Biotechnology from the University of the Philippines, with a thesis on DNA vaccine development for dengue fever. She finished medical school at the University of Santo Tomas, graduating cum laude. She completed internal medicine residency and adult nephrology fellowship at the University of the Philippines- Philippine General Hospital. She has a solid background in hemodialysis facility quality assurance and is a visiting faculty at Aesculap Academy, a global interdisciplinary network offering medical training for physicians and allied health professionals. She is a member of the International Society of Nephrology, the Philippine Society of Nephrology, and the Philippine College of Physicians.
David is responsible for planning and executing data analyses related to QURE’s core business, as well as guiding and overseeing the overall analytics and statistical modeling projects of the analytics team.
David received his Master of Public Health from Dartmouth College in 2003, with an emphasis in quality improvement and biostatistics, and a Bachelor of Science in Electrical Engineering from the University of California, Irvine. David has over ten years of experience related to healthcare analysis and outcomes, and he has been a contributing author to over a dozen peer-reviewed articles. Prior to this, he worked in semiconductor technology at IBM, where he fulfilled several technical and information technology roles for US and international clients to enable the success of a multiple projects.
David Paculdo, MPH
Director, Analytics and Research
Ready to unlock a new era of healthcare excellence?